Data / Research funding / New York / New York Genome Center
New York Genome Center: 31 NIH awards ($88.4M) and 1 NSF award ($319.8K), fiscal years 2021 to 2026
New York Genome Center in New York, NY is funded under 31 NIH awards ($88.4M) and 1 NSF award ($319.8K) in the NIH and NSF award files, read 2026-11-04. NIH fiscal years 2021 to 2025; NSF fiscal years 2022 to 2026.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- UEI
- WKPTJDWG2C68
- State
- New York
Awards
32 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| Center for Integrated Cellular Analysis | NIH | National Human Genome Research Institute | 2021 to 2025 | $20,096,749 | June 1, 2020 | August 31, 2029 | SATIJA, RAHUL | reporter.nih.gov |
| UNSPECIFIED [23-005143] | NIH | National Institute on Drug Abuse | 2023 to 2025 | $17,674,438 | May 29, 2023 | May 28, 2026 | GERMER, SOREN | reporter.nih.gov |
| Comprehensive reference atlas construction, geolocation and data integration for HuBMAP HIVE [5 of 5] | NIH | Office of the Director, National Institutes of Health | 2022 to 2025 | $6,098,553 | August 1, 2022 | July 31, 2026 | SATIJA, RAHUL | reporter.nih.gov |
| ADDING ADDITIONAL FUNDS FOR OPTION PERIOD 1 FOR TOPMED CENTRALIZED OMICS RESOURCE (CORE) YEAR 5 | NIH | National Heart, Lung, and Blood Institute | 2021 | $5,640,230 | September 28, 2020 | September 27, 2022 | REEVES, CATHERINE | reporter.nih.gov |
| New York Genome Characterization Center: Somatic Mosaicism across Human Tissues | NIH | National Institute on Drug Abuse | 2023 to 2025 | $5,476,597 | May 1, 2023 | April 30, 2026 | GERMER, SOREN | reporter.nih.gov |
| NHLBI TRANS-OMICS FOR PRECISION MEDICINE (TOPMED) FOR THE CENTRALIZED OMICS RESOURCE (CORE) | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $3,793,717 | September 23, 2025 | September 22, 2026 | reporter.nih.gov | |
| Multiscale genome engineering to map cis-regulatory variants in human and mouse | NIH | National Human Genome Research Institute | 2023 to 2025 | $3,334,063 | September 15, 2023 | June 30, 2027 | SANJANA, NEVILLE | reporter.nih.gov |
| Delineating the network effects of mental disorder-associated variants using convex optimization methods | NIH | National Institute of Mental Health | 2022 to 2025 | $3,110,527 | August 1, 2022 | May 31, 2027 | KNOWLES, DAVID ARTHUR | reporter.nih.gov |
| Integrating Spatial Multi-omics and Clinical Covariates to Identify Mechanisms of Disease in ALS-FTD | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $3,108,178 | August 15, 2020 | April 30, 2026 | PHATNANI, HEMALI | reporter.nih.gov |
| LTBR CARs as next-generation therapies for R/R lymphoma | NIH | National Cancer Institute | 2023 to 2025 | $2,404,689 | April 10, 2023 | March 31, 2028 | SANJANA, NEVILLE | reporter.nih.gov |
| Spatially Resolved Dynamics of Molecular Pathology and Intercellular Interactions in Amytrophic Lateral Sclerosis | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $2,228,134 | February 1, 2020 | January 31, 2026 | PHATNANI, HEMALI | reporter.nih.gov |
| Statistical Methods for Characterizing Molecular Mechanisms of Human Tissue Development and Disease | NIH | National Human Genome Research Institute | 2024 | $1,799,133 | September 24, 2024 | August 31, 2027 | LAPPALAINEN, TUULI | reporter.nih.gov |
| Studying the Regulatory Dynamics with Single-cell Multiomics | NIH | National Institute of General Medical Sciences | 2023 | $1,737,000 | September 1, 2023 | August 31, 2026 | ZHU, CHENXU | reporter.nih.gov |
| Scalable multi-ancestry functional genomics of blood traits and cardiovascular disease | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,624,547 | July 15, 2024 | June 30, 2028 | SANJANA, NEVILLE | reporter.nih.gov |
| Fine-mapping psychiatricdisease variants that affect post-transcriptional gene regulation | NIH | National Institute of Mental Health | 2021 to 2022 | $1,501,550 | July 5, 2021 | June 30, 2024 | KNOWLES, DAVID ARTHUR | reporter.nih.gov |
| Advanced development of Lancet, an emerging tool for complex variant calling in cancer genomics | NIH | National Cancer Institute | 2021 to 2023 | $1,466,968 | September 20, 2021 | May 31, 2025 | NARZISI, GIUSEPPE | reporter.nih.gov |
| 2/5 Clinical Outcome Prediction of Psychosis from Electronic Health Records (COPPER) | NIH | National Institute of Mental Health | 2024 to 2025 | $1,424,534 | September 6, 2024 | May 31, 2029 | ZODY, MICHAEL C | reporter.nih.gov |
| Comprehensive reference map construction, geolocation and data integration for HuBMAP HIVE | NIH | Office of the Director, National Institutes of Health | 2021 | $1,273,213 | June 21, 2021 | June 20, 2022 | SATIJA, RAHUL | reporter.nih.gov |
| Privacy Preservation in Transcriptomic Data Analysis | NIH | National Human Genome Research Institute | 2024 | $855,711 | September 23, 2024 | August 31, 2025 | GURSOY, GAMZE | reporter.nih.gov |
| Studying the Mammalian Regulatory Circuits by Developing Single-cell Multi-omics Technologies | NIH | National Human Genome Research Institute | 2022 to 2024 | $742,480 | July 1, 2022 | April 30, 2025 | ZHU, CHENXU | reporter.nih.gov |
| A CRISPR/Cas13 approach for identifying individual transcript isoform function in cancer | NIH | National Cancer Institute | 2022 to 2023 | $699,316 | September 1, 2022 | August 31, 2025 | KNOWLES, DAVID ARTHUR | reporter.nih.gov |
| In situ functional genomics to understand transcriptional regulation | NIH | National Human Genome Research Institute | 2022 | $579,000 | June 1, 2022 | May 31, 2023 | SANJANA, NEVILLE | reporter.nih.gov |
| Regulatory modifiers of coding variant penetrance via haplotype epistasis in human populations and diseases | NIH | National Institute of General Medical Sciences | 2021 | $347,458 | May 1, 2017 | April 30, 2023 | LAPPALAINEN, TUULI | reporter.nih.gov |
| POSE: Phase I: Creation of an Open Source Ecosystem to Repurpose DNA Sequencers as an Automation Platform | NSF | Pathways for Translation Section | 2025 | $319,753 | July 15, 2025 | June 30, 2026 | Sanja Vickovic | nsf.gov |
| SAMBAI - Social, Ancestry, Molecular Biology analyses of Inequities | NIH | National Cancer Institute | 2024 | $258,643 | May 1, 2024 | April 30, 2026 | ROBINE, NICOLAS | reporter.nih.gov |
| Comprehensive mapping of multimodal chromatin state in single cells | NIH | National Human Genome Research Institute | 2021 to 2022 | $231,256 | January 1, 2021 | December 31, 2022 | STUART, TIM | reporter.nih.gov |
| Perturbation-response approaches to determining the regulatory networks underlying human complex traits | NIH | National Human Genome Research Institute | 2022 to 2023 | $230,040 | July 18, 2022 | July 31, 2024 | BROWN, BRIELIN | reporter.nih.gov |
| Integrated analyses of the epigenome to understand the molecular basis of hematopoietic malignancies | NIH | National Cancer Institute | 2022 to 2023 | $179,444 | December 15, 2021 | August 11, 2023 | SRIVASTAVA, AVI | reporter.nih.gov |
| Measuring allele and isoform-specific RBP binding to improve predictive models of RNA splicing | NIH | National Institute of General Medical Sciences | 2021 to 2022 | $133,576 | April 1, 2021 | March 31, 2023 | SCHERTZER, MEGAN | reporter.nih.gov |
| Linking GWAS variants to function with single-cell pooled CRISPR screens | NIH | National Human Genome Research Institute | 2023 to 2024 | $123,206 | February 16, 2023 | March 29, 2024 | MORRIS, JOHN ALLAN | reporter.nih.gov |
| Disentangling Tissue and Ome Shared and Private Effects of Exercise | NIH | National Institute on Aging | 2025 | $96,500 | September 23, 2025 | August 31, 2026 | KNOWLES, DAVID ARTHUR | reporter.nih.gov |
| Myeloid cell-expressed PTPN22 and anti-tumor immunity | NIH | National Cancer Institute | 2024 | $91,204 | August 1, 2022 | February 26, 2025 | ACERO BEDOYA, SANTIAGO | reporter.nih.gov |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 11 | $28,959,508 | 1 | $319,753 |
| 2024 | 17 | $14,964,359 | 0 | $0 |
| 2023 | 17 | $22,507,116 | 0 | $0 |
| 2022 | 14 | $8,893,896 | 0 | $0 |
| 2021 | 10 | $13,035,775 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
Topics of its NIH awards
- Genetics
- Human Genome
- Biotechnology
- Bioengineering
- Networking and Information Technology R&D (NITRD)
- Brain Disorders
- Cancer
- Neurosciences
- Precision Medicine
- Machine Learning and Artificial Intelligence
- Clinical Research
- Stem Cell Research
Updated November 4, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-04). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.